Tumour-associated and non-tumour-associated microbiota: Addendum

被引:26
|
作者
Flemer, Burkhardt [1 ,2 ,3 ]
Herlihy, Maeve [4 ]
O'Riordain, Micheal [4 ]
Shanahan, Fergus [1 ,4 ]
O'Toole, Paul W. [1 ,2 ,3 ]
机构
[1] APC Microbiome Inst, Cork, Ireland
[2] Sch Microbiol, Cork, Ireland
[3] Sch Med, Cork, Ireland
[4] Natl Univ Ireland, Univ Coll Cork, Sch Med, Galway, Ireland
基金
爱尔兰科学基金会;
关键词
colorectal cancer; gut microbiota; survival;
D O I
10.1080/19490976.2018.1435246
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In a recent study(1) we reported that tissue-associated microbial Co-abundance Groups (CAGs) were differentially associated with colorectal cancer (CRC). Two of the CAGs, which we named Pathogen CAG and Prevotella CAG, were correlated with a gene expression signature indicative of a TH17 response. A TH17 response has been associated with decreased survival in patients with CRC2, and members of the Pathogen CAG such as Fusobacterium nucleatum, Escherichia coli and Bacteroides fragilis have been repeatedly reported to be associated with CRC-development. Thus we hypothesized that the abundance of these CAGs may be associated with poor survival. In this Addendum we extend our analysis of the at-surgery microbiota to microbiota profiles obtained after surgery for CRC which we analyzed in the context of survival data for patients with CRC. Surprisingly we found that high tissue-associated abundance of the previously defined Prevotella- and Pathogen-CAGs at surgery was associated with longer survival. Furthermore, we detected an association of the Bacteroidetes CAG in pre-surgery faecal microbiota with stability of the microbiota after surgery.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 50 条
  • [1] Tumour-associated and non-tumour-associated microbiota in colorectal cancer
    Al-Hassi, Hafid Omar
    Ng, Oliver
    Brookes, Matthew
    [J]. GUT, 2018, 67 (02)
  • [2] Tumour-associated and non-tumour-associated microbiota in colorectal cancer
    Flemer, Burkhardt
    Lynch, Denise B.
    Brown, Jillian M. R.
    Jeffery, Ian B.
    Ryan, Feargal J.
    Claesson, Marcus J.
    O'Riordain, Micheal
    Shanahan, Fergus
    O'Toole, Paul W.
    [J]. GUT, 2017, 66 (04) : 633 - 643
  • [3] Tumour-associated and non-tumour-associated bacteria co-abundance groups in colorectal cancer
    Liang, Yuxuan
    Zhang, Qingrong
    Yu, Jing
    Hu, Wenyan
    Xu, Sihua
    Xiao, Yiyuan
    Ding, Hui
    Zhou, Jiaming
    Chen, Haitao
    [J]. BMC MICROBIOLOGY, 2024, 24 (01):
  • [4] Profiling of tumour-associated microbiota in human hepatocellular carcinoma
    Komiyama, Seiga
    Yamada, Takahiro
    Takemura, Nobuyuki
    Kokudo, Norihiro
    Hase, Koji
    Kawamura, Yuki, I
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Profiling of tumour-associated microbiota in human hepatocellular carcinoma
    Seiga Komiyama
    Takahiro Yamada
    Nobuyuki Takemura
    Norihiro Kokudo
    Koji Hase
    Yuki I. Kawamura
    [J]. Scientific Reports, 11
  • [6] The tumour-associated microbiome
    Johnston, Christopher D.
    Bullman, Susan
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (06) : 347 - 348
  • [7] The tumour-associated microbiome
    Christopher D. Johnston
    Susan Bullman
    [J]. Nature Reviews Gastroenterology & Hepatology, 2022, 19 : 347 - 348
  • [8] Identifying tumour-associated antigens
    Charlotte Harrison
    [J]. Nature Reviews Drug Discovery, 2012, 11 (5) : 354 - 354
  • [9] Targeting tumour-associated macrophages
    Sica, Antonio
    Rubino, Luca
    Mancino, Alessandra
    Larghi, Paola
    Porta, Chiara
    Rimoldi, Monica
    Solinas, Graziella
    Locati, Massimo
    Allavena, Paola
    Mantovani, Alberto
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (09) : 1219 - 1229
  • [10] Targeting tumour-associated bacteria
    Crunkhorn, Sarah
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (12) : 955 - 955